Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1964 Jun;22(3):463–477. doi: 10.1111/j.1476-5381.1964.tb01701.x

Mechanism of the paralysing action of piperazine on ascaris muscle

J Del Castillo, W C De Mello, T Morales
PMCID: PMC1703942  PMID: 14211677

Abstract

The effects of piperazine on Ascaris muscle cells have been investigated with electrophysiological techniques. These cells have an average resting potential of about 30 mV interrupted by rhythmic spikes of myogenic origin (1 to 7 spikes/sec). With piperazine (10-3, w/v), the average resting potential increases above 40 mV and the pacemaker activity is suppressed. These changes are similar to those temporarily produced in the same cells by the electrical stimulation of inhibitory nerve fibres. Electrophoretic application of piperazine to different areas of the muscle cells shows that this drug hyperpolarizes their membrane only when applied to the region where both excitatory and inhibitory neuromuscular synapses are located. The degree of muscle hyperpolarization induced by piperazine depends upon the extracellular chloride concentration, decreasing when a fraction of the chloride ions is replaced by the larger, supposedly nonpenetrating, sulphate anions. Piperazine may, therefore, be regarded as a pharmacological analogue of a natural inhibitory transmitter.

Full text

PDF
463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUEDING E. Formation of tiglic and n-valeric acids by bacteria-free Ascaris lumbricoides. J Biol Chem. 1953 Jun;202(2):505–512. [PubMed] [Google Scholar]
  2. BUEDING E., SAZ H. J., FARROW G. W. The effect of piperazine on succinate production by Ascaris lumbricoides. Br J Pharmacol Chemother. 1959 Dec;14:497–500. doi: 10.1111/j.1476-5381.1959.tb00955.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DEBELL J. T., DELCASTILLO J., SANCHEZ V. ELECTROPHYSIOLOGY OF THE SOMATIC MUSCLE CELLS OF ASCARIS LUMBRICOIDES. J Cell Physiol. 1963 Oct;62:159–177. doi: 10.1159/000007808. [DOI] [PubMed] [Google Scholar]
  4. DELCASTILLO J., MORALES T. A., SANCHEZ V. ACTION OF PIPERAZINE ON THE NEUROMUSCULAR SYSTEM OF ASCARIS LUMBRICOIDES. Nature. 1963 Nov 16;200:706–707. doi: 10.1038/200706a0. [DOI] [PubMed] [Google Scholar]
  5. ELLISON T., THOMSON W. A., STRONG F. M. Volatile fatty acids from axenic Ascaris lumbricoides. Arch Biochem Biophys. 1960 Dec;91:247–254. doi: 10.1016/0003-9861(60)90498-7. [DOI] [PubMed] [Google Scholar]
  6. GOODWIN L. G., STANDEN O. D. Treatment of roundworm with piperazine citrate: antepar. Br Med J. 1954 Dec 4;2(4900):1332–1333. doi: 10.1136/bmj.2.4900.1332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GOODWIN L. G., VAUGHANWILLIAMS E. M. INHIBITION AND NEUROMUSCULAR PARALYSIS IN ASCARIS LUMBRICOIDES. J Physiol. 1963 Oct;168:857–871. doi: 10.1113/jphysiol.1963.sp007227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HODGKIN A. L., KATZ B. The effect of sodium ions on the electrical activity of giant axon of the squid. J Physiol. 1949 Mar 1;108(1):37–77. doi: 10.1113/jphysiol.1949.sp004310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. JARMAN M. Electrical activity in the muscle cells of Ascaris lumbricoides. Nature. 1959 Oct 17;184(Suppl 16):1244–1244. doi: 10.1038/1841244a0. [DOI] [PubMed] [Google Scholar]
  10. KUFFLER S. W., EYZAGUIRRE C. Synaptic inhibition in an isolated nerve cell. J Gen Physiol. 1955 Sep 20;39(1):155–184. doi: 10.1085/jgp.39.1.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. NORTON S., DE BEER E. J. Investigations on the action of piperazine on Ascaris lumbricoides. Am J Trop Med Hyg. 1957 Sep;6(5):898–905. doi: 10.4269/ajtmh.1957.6.898. [DOI] [PubMed] [Google Scholar]
  12. STANDEN O. D. Activity of piperazine, in vitro, against Ascaris lumbricoides. Br Med J. 1955 Jul 2;2(4930):20–22. doi: 10.1136/bmj.2.4930.20-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES